Literature DB >> 29433091

The influence of lower limb impairments on RaceRunning performance in athletes with hypertonia, ataxia or athetosis.

Marietta L van der Linden1, Sadaf Jahed2, Nicola Tennant3, Martine H G Verheul4.   

Abstract

OBJECTIVES: RaceRunning enables athletes with limited or no walking ability to propel themselves independently using a three-wheeled running bike that has a saddle and a chest plate for support but no pedals. For RaceRunning to be included as a Para athletics event, an evidence-based classification system is required. Therefore, the aim of this study was to assess the association between a range of impairment measures and RaceRunning performance.
METHODS: The following impairment measures were recorded: lower limb muscle strength assessed using Manual Muscle Testing (MMT), selective voluntary motor control assessed using the Selective Control Assessment of the Lower Extremity (SCALE), spasticity recorded using both the Australian Spasticity Assessment Score (ASAS) and Modified Ashworth Scale (MAS), passive range of motion (ROM) of the lower extremities and the maximum static step length achieved on a stationary bike (MSSL). Associations between impairment measures and 100-meter race speed were assessed using Spearman's correlation coefficients.
RESULTS: Sixteen male and fifteen female athletes (27 with cerebral palsy), aged 23 (SD = 7) years, Gross Motor Function Classification System levels ranging from II to V, participated. The MSSL averaged over both legs and the ASAS, MAS, SCALE, and MMT summed over all joints and both legs, significantly correlated with 100 m race performance (rho: 0.40-0.54). Passive knee extension was the only ROM measure that was significantly associated with race speed (rho = 0.48).
CONCLUSION: These results suggest that lower limb spasticity, isometric leg strength, selective voluntary motor control and passive knee extension impact performance in RaceRunning athletes. This supports the potential use of these measures in a future evidence-based classification system.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral Palsy; Para athletics; RaceRunning; Running; Selective Motor control; Spasticity

Mesh:

Year:  2018        PMID: 29433091     DOI: 10.1016/j.gaitpost.2018.02.004

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  5 in total

1.  Using Decision Trees to Support Classifiers' Decision-Making about Activity Limitation of Cerebral Palsy Footballers.

Authors:  José M Sarabia; Alba Roldan; Matías Henríquez; Raul Reina
Journal:  Int J Environ Res Public Health       Date:  2021-04-19       Impact factor: 3.390

2.  To What Degree Does Limb Spasticity Affect Motor Performance in Para-Footballers With Cerebral Palsy?

Authors:  Alba Roldan; Matías Henríquez; Aitor Iturricastillo; Daniel Castillo; Javier Yanci; Raul Reina
Journal:  Front Physiol       Date:  2022-01-24       Impact factor: 4.566

3.  Athlete-Perceived Impact of Frame Running on Physical Fitness, Functional Mobility and Psychosocial Outcomes.

Authors:  Marietta L Van der Linden; Petra E M Van Schie; Emma Hjalmarsson; Georgia Andreopoulou; Martine H G Verheul; Ferdinand Von Walden
Journal:  J Rehabil Med       Date:  2022-03-01       Impact factor: 2.912

4.  Study protocol for Running for health (Run4Health CP): a multicentre, assessor-blinded randomised controlled trial of 12 weeks of two times weekly Frame Running training versus usual care to improve cardiovascular health risk factors in children and youth with cerebral palsy.

Authors:  Sarah E Reedman; Leanne Sakzewski; Lynda McNamara; Catherine Sherrington; Emma Beckman; Kerry West; Stewart G Trost; Rachel Thomas; Mark D Chatfield; Iain Dutia; Alix Gennen; Bridget Dodds; Zoë Cotton; Roslyn N Boyd
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

5.  RaceRunning training improves stamina and promotes skeletal muscle hypertrophy in young individuals with cerebral palsy.

Authors:  Emma Hjalmarsson; Rodrigo Fernandez-Gonzalo; Cecilia Lidbeck; Alexandra Palmcrantz; Angel Jia; Ola Kvist; Eva Pontén; Ferdinand von Walden
Journal:  BMC Musculoskelet Disord       Date:  2020-03-27       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.